Bing-Neel Syndrome, a Rare Manifestation of Waldenström Macroglobulinemia Evaluated by 18 FFDG PET/CT: Diagnostic Impact in a Challenging Case (EANM 2026) - Sep 29, 2026 - Abstract #EP-1329; "The patient was treated with 6 cycles of RCD (Rituximab, Cyclophosphamide and Dexamethasone), achieving a partial response...Multiple therapies were administered, including Rituximab-based chemoimmunotherapy, Bendamustine, Venetoclax and intrathecal targeted chemotherapy... This case highlights the aggressive nature of Waldenström macroglobulinemia with Bing-Neel syndrome. [18F]-FDG PET/CT proved valuable in detecting neurological infiltration, monitoring disease progression and guiding therapeutic decisions. nah A, Al Hadidi S. Bing-Neel Syndrome: Update on the Diagnosis and Treatment."
Clinical • B Cell Non-Hodgkin Lymphoma • Hematological Disorders • Hematological Malignancies • Lymphoma • Lymphoplasmacytic Lymphoma • Monoclonal Gammopathy • Multiple Myeloma • Non-Hodgkin's Lymphoma • Waldenstrom Macroglobulinemia
|
|
S. Marian 1; A. Jougla 1; A. Cochet 1, 2
|